CBG authorized for use in cosmetics by the European Union
The European Commission has added cannabigerol (CBG) to the EU's cosmetic ingredients database (Cosing), meaning that this compound is safe for use in health and beauty products.
The CBG acts on the CB1 and CB2 endocannabinoid receptors located in the skin. Cannabigerol has anti-inflammatory, antibacterial and antioxidant properties that help the endocannabinoid system maintain healthy skin function.
Once CBG penetrates the epidermis, it reaches the basal and subcutaneous layers of the skin, where it helps calm inflammation, reduce blemishes, purify pores, balance sebum production and improve cell renewal.
CBG is known as the «mother» cannabinoid, the precursor of all other cannabinoids such as CBD, CBN, CBC or THC in their acid form.
CBD of natural origin, which has been added to the Cosing database at the beginning of the year, and synthetic CBD, are also authorized for use in EU cosmetics, just like hemp leaves.
CBG registration at Cosing can be seen here.
-
Business3 weeks ago
The legal cannabis market in New York exceeds 4 billion $ in revenue
-
Cannabis in France4 weeks ago
Which countries legalized medical cannabis before France?
-
Cannabis in France1 week ago
France already has 3,000 cannabis retail outlets. None of them are legal.
-
Business4 weeks ago
South Korea is preparing to begin local production of medical cannabis to meet rising demand
-
Cannabis in the U.S.1 week ago
A DEA report confirms that there are no fatal cannabis overdoses
-
Cannabis in Thailand4 weeks ago
From the boom in dispensaries to a purely medical approach: Thailand is revising its cannabis policy
-
Cannabis and driving4 weeks ago
Medical Cannabis and Driving: New South Wales Ends Automatic Penalties for THC
-
Cannabis in France3 weeks ago
France’s Drug Policy Chief Defends Cannabis Prohibition... and Runs Into the Facts


You must be logged in to post a comment Login